Physiologically Based Pharmacokinetic Modeling in Pediatric Drug Development: A Clinician’s Request for a More Integrated Approach

Physiologically Based Pharmacokinetic Modeling in Pediatric Drug Development: A Clinician’s Request for a More Integrated Approach

Bibliographic Details
Main Authors:	Karel Allegaert, Anne Smits, Johannes N. van den Anker
Format:	Article
Language:	English
Published:	Hindawi Limited 2012-01-01
Series:	Journal of Biomedicine and Biotechnology
Online Access:	http://dx.doi.org/10.1155/2012/103763

Similar Items

A Physiology-Based Pharmacokinetic Framework to Support Drug Development and Dose Precision During Therapeutic Hypothermia in Neonates
by: Anne Smits, et al.
Published: (2020-05-01)

Mechanistic Coupling of a Novel in silico Cotyledon Perfusion Model and a Physiologically Based Pharmacokinetic Model to Predict Fetal Acetaminophen Pharmacokinetics at Delivery
by: Paola Mian, et al.
Published: (2021-09-01)

Creatinine Trends to Detect Ibuprofen-Related Maturational Adverse Drug Events in Neonatal Life: A Simulation Study for the ELBW Newborn
by: Tamara van Donge, et al.
Published: (2021-01-01)

Adverse drug events in pediatric intensive care are common, but improvement strategies exist and are effective
by: Karel Allegaert

Physiologically Based Pharmacokinetic Modeling and Simulation in Pediatric Drug Development
by: A R Maharaj, et al.
Published: (2014-11-01)

Maternal analgosedation and breastfeeding: guidance for the pediatrician
by: Karel Allegaert, et al.
Published: (2015-03-01)

Amikacin or Vancomycin Exposure Alters the Postnatal Serum Creatinine Dynamics in Extreme Low Birth Weight Neonates
by: Tamara van Donge, et al.
Published: (2021-01-01)

Renal Precision Medicine in Neonates and Acute Kidney Injury: How to Convert a Cloud of Creatinine Observations to Support Clinical Decisions
by: Karel Allegaert, et al.
Published: (2020-07-01)

Rational Use of Antibiotics in Neonates: Still in Search of Tailored Tools
by: John van den Anker, et al.
Published: (2019-02-01)

Clinical pharmacokinetics of vancomycin in the neonate: a review
by: Gian Maria Pacifici, et al.
Published: (2012-07-01)

Acute Maternal Fasting or Fluid Abstention Does Not Significantly Affect the Macronutrient Composition of Human Milk: Clinical and Clinical Research Relevance
by: Karel Allegaert, et al.
Published: (2020-06-01)

The Neonatal and Juvenile Pig in Pediatric Drug Discovery and Development
by: Miriam Ayuso, et al.
Published: (2021-12-01)

The Impact of Caesarean Delivery on Paracetamol and Ketorolac Pharmacokinetics: A Paired Analysis
by: Aida Kulo, et al.
Published: (2012-01-01)

Population pharmacokinetic modeling to facilitate dose selection of tapentadol in the pediatric population
by: Watson E, et al.
Published: (2019-10-01)

A best practice framework for applying physiologically‐based pharmacokinetic modeling to pediatric drug development
by: Trevor N. Johnson, et al.
Published: (2021-09-01)

Persistent Pharmacokinetic Challenges to Pediatric Drug Development
by: Daniel eSage, et al.
Published: (2014-08-01)

Physiologically-Based Pharmacokinetic (PBPK) Modeling Providing Insights into Fentanyl Pharmacokinetics in Adults and Pediatric Patients
by: Lukas Kovar, et al.
Published: (2020-09-01)

Physiologically‐Based Pharmacokinetic Modeling vs. Allometric Scaling for the Prediction of Infliximab Pharmacokinetics in Pediatric Patients
by: Paul R. V. Malik, et al.
Published: (2019-11-01)

Perinatal Pharmacology
by: Karel Allegaert, et al.
Published: (2014-01-01)

Prediction of the pharmacokinetics and pharmacodynamics of topiroxostat in humans by integrating the physiologically based pharmacokinetic model with the drug-target residence time model
by: Zhiqiang Luo, et al.
Published: (2020-01-01)

In-Hospital Outcomes of Acute Kidney Injury After Pediatric Cardiac Surgery: A Meta-Analysis
by: Jef Van den Eynde, et al.
Published: (2021-09-01)

Physiologically Based Pharmacokinetic Modeling: Methodology, Applications, and Limitations with a Focus on Its Role in Pediatric Drug Development
by: Feras Khalil, et al.
Published: (2011-01-01)

Enantiomer-specific ketorolac pharmacokinetics in young women, including pregnancy and postpartum period
by: Aida Kulo, et al.
Published: (2017-02-01)

Retrospective evaluation of single patient investigational new drug (IND) requests in pediatric oncology
by: David S. Shulman, et al.
Published: (2021-04-01)

Prediction of pharmacokinetic drug-drug interactions causing atorvastatin-induced rhabdomyolysis using physiologically based pharmacokinetic modelling
by: Size Li, et al.
Published: (2019-11-01)

Development of a physiologically-based pharmacokinetic pediatric brain model for prediction of cerebrospinal fluid drug concentrations and the influence of meningitis.
by: Laurens F M Verscheijden, et al.
Published: (2019-06-01)

Design and Testing of an EHR-Integrated, Busulfan Pharmacokinetic Decision Support Tool for the Point-of-Care Clinician.
by: Susan M. Abdel-Rahman, et al.
Published: (2016-03-01)

Effective analgesia after cesarean delivery needs pharmacokinetic input
by: Aida Kulo, et al.
Published: (2012-01-01)

Physiological and Pharmacokinetic Alterations and Drug-Nutrient Interactions During Pregnancy
by: Gözde Ede, et al.
Published: (2017-09-01)

Complementary and integrative medicine: An observational study on pediatric clinicians’ knowledge, beliefs and practices
by: Nicole Casbarro, et al.
Published: (2021-05-01)

Where are the Ambulatory Care Pediatric Pharmacists?
by: Richard H. Parrish, et al.
Published: (2019-02-01)

Development and evaluation of physiologically based pharmacokinetic drug-disease models for predicting captopril pharmacokinetics in chronic diseases
by: Muhammad F. Rasool, et al.
Published: (2021-04-01)

Modern pharmacokinetic-pharmacodynamic techniques to study physiological mechanisms of pharmacokinetic drug-drug interactions and disposition of antibiotics and to assess clinical relevance
by: Landersdorfer, Cornelia
Published: (2006)

Physiologically Based Pharmacokinetic Modeling of Monoclonal Antibodies in Pediatric Populations Using PK-Sim
by: Sumit Basu, et al.
Published: (2020-06-01)

A Critical Review on the Relevance of Paracetamol for Procedural Pain Management in Neonates
by: Karel Allegaert, et al.
Published: (2020-03-01)

Physiologically based pharmacokinetic (PBPK) modeling and simulation in drug discovery and development
by: Abdul Naveed Shaik, et al.
Published: (2019-02-01)

Pharmacometric Evaluation of Umbilical Cord Blood Concentration-Based Early Initiation of Treatment in Methadone-Exposed Preterm Neonates
by: Samira Samiee-Zafarghandy, et al.
Published: (2021-02-01)

Physiologically‐Based Pharmacokinetic Model‐Informed Drug Development for Fenebrutinib: Understanding Complex Drug‐Drug Interactions
by: Yuan Chen, et al.
Published: (2020-06-01)

Different Vancomycin Immunoassays Contribute to the Variability in Vancomycin Trough Measurements in Neonates
by: Janko Samardzic, et al.
Published: (2016-01-01)

Assessing the usability by clinicians of VISION: A hierarchical display of patient-collected physiological information to clinicians
by: Cubby L. Gardner, et al.
Published: (2017-04-01)